Matthew Reynolds to Warfarin
This is a "connection" page, showing publications Matthew Reynolds has written about Warfarin.
Connection Strength
1.134
-
Reynolds MR. Cardioversion with novel oral anticoagulants: reconfirming a 50-year-old standard. J Am Coll Cardiol. 2014 Mar 25; 63(11):1088-9.
Score: 0.396
-
Reynolds MR. Discontinuation of rivaroxaban: filling in the gaps. J Am Coll Cardiol. 2013 Feb 12; 61(6):659-60.
Score: 0.377
-
Reynolds MR, Shah J, Essebag V, Olshansky B, Friedman PA, Hadjis T, Lemery R, Bahnson TD, Cannom DS, Josephson ME, Zimetbaum P. Patterns and predictors of warfarin use in patients with new-onset atrial fibrillation from the FRACTAL Registry. Am J Cardiol. 2006 Feb 15; 97(4):538-43.
Score: 0.230
-
Reynolds MR, Allison JS, Natale A, Weisberg IL, Ellenbogen KA, Richards M, Hsieh WH, Sutherland J, Cannon CP. A Prospective Randomized Trial of?Apixaban Dosing During Atrial?Fibrillation?Ablation: The?AEIOU Trial. JACC Clin Electrophysiol. 2018 05; 4(5):580-588.
Score: 0.132